ACRO Biomedical Co Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

0.06

EPS

—

Div Yield, %

—

Shrs. gr., 5y

4.94%

Rev. gr., 5y

5.24%

Revenues

659k

-45.01%

Net income

-16m

L+106.07%

CFO

-147k

Profile

Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.

URL

http://acrobiomedicalco.com

IPO date

Jun 23, 2016

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2022‑12	2021‑12	2020‑12	2019‑12	2018‑09	2017‑09	2016‑09	2015‑09
Income
Revenues	658 -45.01%
Cost of revenue	10,598
Unusual Expense (Income)
NOPBT	(9,940)
NOPBT Margin
Operating Taxes	(15,870)
Tax Rate
NOPAT	5,930
Net income	(15,871) 106.07%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current	26
Long-term debt	26
Deferred revenue
Other long-term liabilities
Net debt	46
Cash flow
Cash from operating activities	(147)
CAPEX
Cash from investing activities
Cash from financing activities	58
FCF	6,023
Balance
Cash	6
Long term investments
Excess cash
Stockholders' equity	(23,748)
Invested Capital	24,260
ROIC	36.13%
ROCE
EV
Common stock shares outstanding	60,042
Price	4.50 -3.23%
Market cap	270,189 7.92%
EV	278,296
EBITDA	(9,940)
EV/EBITDA
Interest	2
Interest/NOPBT